A Study to Compare Banadiqul Bazoor with Nitrofurantoin for Treating Acute Cystitis (Warm-e-Masana Had)

An Open-Labelled Randomised Controlled Clinical Trial to Evaluate the Safety & Efficacy of Banadiqul Bazoor in Cases of Warm-e-Masana (Had Acute Cystitis) with Nitrofurantoin - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099670

Enrollment

Registered

2025-12-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N300- Acute cystitis

Interventions

Intervention1: Banadiqul Bazoor: Therapy Duration: 30 days Sample Size: 25 participants Treatment Plan: Group A: Banadiqul Bazoor 2 tablets BD (twice daily) after meals for 30 days, with follow-ups

Eligibility

Inclusion criteria

Inclusion criteria: Age limit 18-60 years. Sex-Both sexes. Patients with burning micturition. Patients with dysuria. Patients with urgency of urine. Patients with frequency of micturition.

Exclusion criteria

Exclusion criteria: Patients with pregnancy and lactation. Patients with renal calculi & vesicle calculi . Patients with uncontrolled hypertensive . Patients with uncontrolled diabetic . Patients with systemic illness like cardiac failure, renal failure, hepatic failure etc.

Design outcomes

Primary

Measure	Time frame
To evaluate the safety and efficacy of banadiqul bazoor in cases of warm e masanaTimepoint: Once in two weeks	—

Secondary

Measure	Time frame
To evaluate the safety and efficacy of Nitrofurantoin in cases of warm e masanaTimepoint: Once in two weeks	—

Countries

India

Contacts

Public ContactN Narasimha

Government Nizamia Tibbi College and General Hospital

dr.n.narasimha@gmail.com9866985269

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026